forum
LALPATHLAB Share Price Target
Dr. Lal Pathlabs Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
LALPATHLAB Share Price *
1,291.05 -33.4 (-2.52%)
* (quote may be delayed)
LALPATHLAB Share Price Forecast - Consensus
| No. of reports in last year | 5 |
| No. of analysts | 2 |
| Average Consensus Forecast | 1120.80 |
| Consensus Potential | -18.92% |
LALPATHLAB Share Price Target - Broker Reports - 2019
Karvy Stock Broking
23-Aug-19
Price @ Call: 1173
Target: 1285
HOLD
We downgrade the stock to a ‘HOLD’ rating and value Dr Lal PathLabs at 38x FY21E EPS of Rs. 33.8 for a target of Rs. 1285. Slower than expected penetration in Rest of North, East and Central India pose a threat to our call.
Prabhudas Lilladher
14-Aug-19
Price @ Call: 1060.4
Target: 1120
ACCUMULATE
Q1 in line; Favorable product mix leads margin
DLPL’s revenue, adj. EBITDA and PAT grew 15%, 21% and 19% YoY respectively in Q1FY20 and in line with our estimates in margin and earnings. With strong cash flow and growth in new customers and packaged offer, the company expects to maintain current growth in FY20E. The expansion of bundle-test offer and gradual ramp up of central lab in Kolkata (KRL) to improve further volume addition in FY20E and FY21E. Management expects competitive intensity to remain strong with price war, regulatory interference and expected price ceiling of government. DLPL remain confident of its brand power, service quality, high-end test capability, network of collection centers and KRL to drive volume growth and profitability in FY19-21E. We maintain“Accumulate” and retain TP at Rs1,120.
DLPL’s revenue, adj. EBITDA and PAT grew 15%, 21% and 19% YoY respectively in Q1FY20 and in line with our estimates in margin and earnings. With strong cash flow and growth in new customers and packaged offer, the company expects to maintain current growth in FY20E. The expansion of bundle-test offer and gradual ramp up of central lab in Kolkata (KRL) to improve further volume addition in FY20E and FY21E. Management expects competitive intensity to remain strong with price war, regulatory interference and expected price ceiling of government. DLPL remain confident of its brand power, service quality, high-end test capability, network of collection centers and KRL to drive volume growth and profitability in FY19-21E. We maintain“Accumulate” and retain TP at Rs1,120.
Prabhudas Lilladher
20-May-19
Price @ Call: 1044.4
Target: 1120
ACCUMULATE
Management expects competitive intensity to remain strong with price war, regulatory interference and an expected price ceiling from the government. DLPL remains confident of its brand power, service quality, high-end test capability, network of collection centers and KRL which will drive volume growth and profitability in FY20-21E. We maintain“Accumulate” and move forward our base of valuation to 32x of FY21E earnings estimates to derive new TP at Rs1,120 (from Rs1,009).
Prabhudas Lilladher
12-Feb-19
Price @ Call: 1021.1
Target: 1070
ACCUMULATE
LALPATHLAB Share Price Target - Broker Reports - 2018
Prabhudas Lilladher
7-Nov-18
Price @ Call: 892.19
Target: 1009
ACCUMULATE
Kotak Securities
13-Aug-18
Price @ Call: 915.5
Target: 900
REDUCE
Edelweiss
15-May-18
Price @ Call: 887.2
Target: 1050
BUY
Prabhudas Lilladher
14-May-18
Price @ Call: 815.9
Target: 1009
ACCUMULATE
Edelweiss
12-Feb-18
Price @ Call: 903
Target: 1050
BUY
LALPATHLAB Share Price Target - Broker Reports - 2017
Prabhudas Lilladher
9-Nov-17
Price @ Call: 817.16
Target: 963
ACCUMULATE
Edelweiss
9-Aug-17
Price @ Call: 821.1
Target: 900
BUY
HDFC Securities
31-Mar-17
Price @ Call: 964.28
Target: 1162.5
BUY
Edelweiss
2-Feb-17
Price @ Call: 1082
Target: 1230
BUY
LALPATHLAB Share Price Target - Broker Reports - 2016
Edelweiss
3-Nov-16
Price @ Call: 1194
Target: 1230
BUY
Edelweiss
14-Oct-16
Price @ Call: 1036.5
Target: 1180
BUY